Quick Answer
Yubo International Biotech Ltd reported Cash and Equivalents of $27.5 thousand for fiscal year 2021.
Yubo International Biotech Ltd Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2021 | $27.5K | -98.0% |
| 2020 | $1.38M | +138152.4% |
| 2020 | $1.0K | -20.8% |
| 2019 | $1.3K | -68.5% |
| 2019 | $4.0K | +100.0% |
| 2018 | $2.0K | +100.0% |
| 2017 | $1.0K | -90.9% |
| 2016 | $11.0K | -8.3% |
| 2015 | $12.0K | +50.0% |
| 2014 | $8.0K | -33.3% |
| 2013 | $12.0K | +71.4% |
| 2012 | $7.0K | +0.0% |
| 2011 | $7.0K | +16.7% |
| 2010 | $6.0K | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| June 30, 2022 | $36.6K | -53.9% | +250.6% |
| March 31, 2022 | $10.4K | -91.7% | -62.1% |
| December 31, 2021 | $27.5K | -98.0% | -56.3% |
| September 30, 2021 | $63.0K | -91.6% | -20.7% |
| June 30, 2021 | $79.4K | -36.1% | -37.1% |
| March 31, 2021 | $126.3K | +402.2% | -90.9% |
| December 31, 2020 | $1.38M | — | — |
| November 30, 2020 | $0.00 | — | -100.0% |
- Yubo International Biotech Ltd showed a decrease of -98.0% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2010–2021 period, Yubo International Biotech Ltd’s cash and equivalents has grown by 358.6% (from $6.0 thousand to $27.5 thousand).
- The most recent figure is from Yubo International Biotech Ltd’s fiscal year 2021 report (Form 10-K), filed with the SEC on April 15, 2022.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: